- Home
- PRTA vs KELYA Comparison
PRTA vs KELYA Comparison
Compare PRTA & KELYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- KELYA
- Stock Information
- Founded
- PRTA 2012
- KELYA 1946
- Country
- PRTA Ireland
- KELYA United States
- Employees
- PRTA N/A
- KELYA N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- KELYA Professional Services
- Sector
- PRTA Health Care
- KELYA Consumer Discretionary
- Exchange
- PRTA Nasdaq
- KELYA Nasdaq
- Market Cap
- PRTA 346.4M
- KELYA 403.0M
- IPO Year
- PRTA N/A
- KELYA N/A
- Fundamental
- Price
- PRTA $6.41
- KELYA $12.46
- Analyst Decision
- PRTA Buy
- KELYA Buy
- Analyst Count
- PRTA 9
- KELYA 1
- Target Price
- PRTA $27.67
- KELYA $25.00
- AVG Volume (30 Days)
- PRTA 1.7M
- KELYA 274.9K
- Earning Date
- PRTA 08-07-2025
- KELYA 08-07-2025
- Dividend Yield
- PRTA N/A
- KELYA 2.36%
- EPS Growth
- PRTA N/A
- KELYA N/A
- EPS
- PRTA N/A
- KELYA N/A
- Revenue
- PRTA $137,935,000.00
- KELYA $4,451,600,000.00
- Revenue This Year
- PRTA N/A
- KELYA $8.06
- Revenue Next Year
- PRTA $122.02
- KELYA $4.08
- P/E Ratio
- PRTA N/A
- KELYA N/A
- Revenue Growth
- PRTA 54.55
- KELYA N/A
- 52 Week Low
- PRTA $4.32
- KELYA $10.80
- 52 Week High
- PRTA $25.42
- KELYA $23.81
- Technical
- Relative Strength Index (RSI)
- PRTA 57.61
- KELYA 58.90
- Support Level
- PRTA $5.96
- KELYA $12.36
- Resistance Level
- PRTA $6.77
- KELYA $12.87
- Average True Range (ATR)
- PRTA 0.36
- KELYA 0.33
- MACD
- PRTA 0.14
- KELYA 0.11
- Stochastic Oscillator
- PRTA 75.80
- KELYA 77.72
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About KELYA Kelly Services Inc.
Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.